Abstract:Objective To describe the clinical features of invasive fungal disease in Huashan Hospital,Fudan University from January 2004to December 2006.Methods The medical data were reviewed retrospectively for the patients with fungal infection,which was confirmed by positive fungal culture or microscopic examination with blood,sterile body fluid,deep tissue,sputum specimen or isolation of Aspergillus spp.and Cryptococcus spp.from bronchoalveolar lavage.The proven and probable cases of invasive fungal disease were included in this analysis.Results A total of 111 patients were diagnosed as invasive fungal disease,including 104 proven cases and 7 probable cases.Sixty-one cases were community-acquired and the other 50 were nosocomial.The most common site of infection was bloodstream(51,45.9%),followed by central nervous system(44,39.6%)and respiratory system(14,12.6%).The most common pathogens were Candidaspp.(50,45%),Cryptococcus(47,42.3%)and Aspergillus spp.(12,10.8%).The communityacquired fungal infections were mostly found in central nervous system(44,72.1%),and respiratory system(12,19.7%),mainly caused by Cryptococcus and Aspergillus.The nosocomial fungal infections occurred primarily in bloodstream(96.0%),mainly due to Candidaspp.No underlying disease or risk factor was identified in more than half of the patients with community-acquired infection,while almost all the patients with nosocomial fungal infection had underlying disease and predisposing factors.Indwelling venous catheter was closely associated with nosocomial bloodstream infection.Indwelling venous catheter lasted for more than 1 week in 64.7% of the patients with Candida bloodstream infection.The same fungal strain was isolated from both the cather and blood of the same patient in11 cases.The overall mortality of these invasive fungal diseases was 14.4%(16/111).The mortality rate was 18.0%(9/50)in the patients with nosocomial invasive fungal infection,and 11.5%(7/61)in the patients with community-acquired invasive fungal infection.Conclusions The most common site of invasive fungal infection is bloodstream,followed by central nervous system,and respiratory system.Majority of the fungal pathogens are Candida spp.,Cryptococcus and Aspergillus spp.The community-acquired invasive fungal disease is primarily meningitis caused by Cryptococcus.The nosocomial invasive fungal disease is mainly bloodstream infection caused by Candida spp.

Clinical analysis of 87 cases of pulmonary fungal infection

Clinical and Non-Clinical Characteristics of Pulmonary Aspergillosis in Non-Neutropenic Patients

Clinical Analysis of Invasive Pulmonary Fungal Infections

Clinical analysis of 103 cases of invasive pulmonary fungal infection

Analysis of clinical characteristics and risk factors of pulmonary fungal infection

Clinical analysis of 62 cases of pulmonary fungal infection in the elderly patients

Clinical Analysis of 18 Pulmonary Aspergillosis Cases

Trends of pulmonary fungal infections from 2013 to 2019: an AI-based real-world observational study in Guangzhou, China

Clinical Analysis on Ninty-Six Cases of Secondary Aspergillosis in COPD Patients

Clinical study of invasive pulmonary fungal infections in acute leukemia patients

Clinical Analysis of Nosocomial Pulmonary Fungal Infections in Medical Ward of Respiration

Analysis of 82 elderly patients with pulmonary fungal infection

Clinical analysis of 30 patients with pulmonary aspergillosis

Clinical feature and antifungal susceptibility analysis of 111 cases of invasive fungal disease

Clinical, Laboratory, Radiological, Bronchoscopic, and Outcome Characteristics of Pulmonary Fungal Infection in Children in PICU in Central China: A Case Series

The clinical features and prognosis of fungal pleural infection: A case series and literature review

A Multicentre Retrospective Study of Pulmonary Mycosis Clinically Proven from 1998 to 2007

[A study of 152 cases of pulmonary fungal infection: reevaluation of the microbiological spectra].

Clinical Analysis of 40 Patients with Pulmonary Aspergillosis

Clinical Analysis of 68 Patients with Pulmonary Mycosis in China.